The Lymphoma Program is a highly interdisciplinary group of investigators dedicated to reducing the incidence and subsequent mortality of lymphoma. The program fosters interdisciplinary research in basic science, genetics, clinical medicine, cancer prevention, and epidemiology at Fred Hutch, the faculty at the University of Washington, and the clinical community to improve lymphoma prevention, detection, diagnosis and treatment.
Forty years ago, researchers at Fred Hutch developed bone marrow transplantation, which continues to be one of the most effective options for patients with lymphoma. Dr. E. Donnall Thomas and his team proved it is possible to replace cancerous cells and stem cells with donated healthy cells that engraft within a patient’s bone marrow. The discovery has created an effective treatment option for lymphoma and other blood cancers, and earned Thomas the 1990 Nobel Prize in physiology or medicine.
Dr. Gopal is a medical oncologist with a primary focus in developing novel targeted therapies for lymphomas with particular emphasis on radioimmunotherapy-based transplant conditioning regimens, low toxicity Proapoptotic agents for indolent lymphomas, and safe curative regimens for older adults with lymphoma.